...
...

balram bhargava news

‘Major safety concerns’: ICMR chief's advice for using Molnupiravir

DG, ICMR Dr Balram Bhargava addressing a press conference.
Published on Jan 05, 2022 06:16 pm IST

ICMR chief lists dos and don’ts during Christmas, New Year amid Omicron

Omicron variant of Covid-19, which was first discovered in South Africa, has been detected in 11 states and UTs in India so far with 101 confirmed infections.
Published on Dec 17, 2021 06:06 pm IST

Don’t delay getting fully vaccinated: Centre after Omicron cases found in India

The Centre said that both patients with Omicron Covid-19 variant in India have mild symptoms. (AFP PHOTO.)
Updated on Dec 02, 2021 11:23 pm IST

Need more data to begin Covid-19 vaccination for children at large: ICMR DG

Need more data to begin Covid-19 vaccination for children, says ICMR DG (Image used for representative purpose only)
Updated on Jun 25, 2021 06:28 pm IST

'Will have enough vaccines by July to inoculate 1 cr people a day': ICMR chief

More than 212 million vaccine doses have been administered in the county, according to Union health ministry.
Published on Jun 01, 2021 06:25 pm IST

India's Covid-19 vaccines will be effective against new variants, says ICMR

The third clinical trial of Covaxin BB152 had been completed as all the 25,800 volunteers involved in the exercise had been administered both doses.
Published on Feb 19, 2021 10:16 am IST

‘Bharat Biotech vaccine approved in clinical trial mode, consent of participants has to be taken’: ICMR

Healthcare workers during a mock drill for dry run of Covid-19 vaccination programme, at MMG hospital in Ghaziabad on Tuesday.
Updated on Jan 06, 2021 10:17 am IST

‘Will take that vaccine...’: Experts explain why Bharat Biotech’s vaccine got approval

Health experts were asked which vaccines they would lie to take between Covishield and Covaxin. (Photo: PIB)
Updated on Jan 05, 2021 09:38 pm IST

‘2 vaccines a result proactive approach,’ says DG-ICMR

Dr Balram Bhargava on Sunday said Covaxin might be more effective to fight the new strain of virus.
Updated on Jan 04, 2021 05:48 am IST

Bharat Biotech vaccine more likely to work against newer strains like UK variant: Vardhan

Union health minister Harsh Vardhan during a mock drill and dry run of Covid-19 vaccination at a model Covid-19 vaccination centre in Ansari Road, New Delhi on Saturday.
Updated on Jan 04, 2021 12:08 am IST

‘Bharat Biotech vaccine may have some advantages...’: ICMR chief on Covaxin, mutant strain

Dr Balram Bhargava on Sunday said Covaxin might be more effective to fight the new strain of virus. (Photo: ANI)
Updated on Jan 03, 2021 08:16 pm IST

Experimental therapies not to be used indiscriminately, warns ICMR

Dr. Balram Bhargava.
Updated on Dec 30, 2020 01:59 am IST

Non-judicious use of therapies for Covid-19 leads to virus mutations: ICMR chief

Speaking in the context of UK Covid-19 virus strain mutation, Dr Bhargava said genetic mutations occur in the respiratory viruses but higher transmissibility is a point of concern.
Published on Dec 29, 2020 09:03 pm IST

ICMR chief Balram Bhargava admitted to AIIMS Trauma Centre for Covid-19 treatment

DG, ICMR Dr. Balram Bhargava addressing a press conference on the actions taken, preparedness, and updates on Covid-19 in New Delhi.
Updated on Dec 18, 2020 10:40 pm IST

‘Need to follow Covid-19 protocol even after vaccine is available, masks here to stay’: ICMR chief

A DCD volunteer wearing face mask walks past a mural on novel coronavirus and protective measures, in New Delhi, on November 24.
Updated on Nov 29, 2020 09:10 am IST

Delhi health minister Satyendar Jain bats for plasma therapy

Delhi health minister Satyendar Jain.
Updated on Oct 22, 2020 06:41 am IST

Plasma therapy may not be used on patients

BMC health workers collect plasma samples from patients who recovered from Covid-19, They come forward to donate blood for the convalescent plasma therapy at Dharavi in Mumbai.
Updated on Oct 21, 2020 02:33 am IST

30 million frontline workers to get Covid-19 vaccine in phase 1

An auto rickshaw drives past a mural depicting frontline workers fighting against Covid-19 in New Delhi.
Updated on Oct 21, 2020 01:35 am IST

ICMR DG hails Gandhian perspective of healthy living in Covid-19 times

ICMR Director-General Balram Bhargava opined that Gandhi was aware and concerned about individual health
Updated on Oct 03, 2020 10:13 am IST

Covid-19: Key highlights of second sero-survey findings

People wearing protective face masks wait in line to get tested for the coronavirus disease (Covid-19), in New Delhi.
Updated on Sept 29, 2020 07:40 pm IST

Delhi LG asks expert panel to suggest measures to tackle Covid-19 situation: Report

Delhi Lt. Governor Anil Baijal addressing a digital press conference over lockdown amid coronavirus pandemic in New Delhi.
Published on Sept 22, 2020 06:33 pm IST

India’s Covid-19 recovery rate surges past 78%, one of the highest globally: Govt

Healthcare workers during Covid-19 screening and swab test at Kandivali(W) in Mumbai on Tuesday.
Updated on Sept 15, 2020 10:25 pm IST

Covid-19: The daredevils who defy scientific advice

What makes a daredevil expect a favourable outcome, of not getting infected, despite reckless behaviour?
Updated on Aug 30, 2020 09:14 pm IST

Clinical study of Covid-19 vaccine on human volunteers now in India

Two vaccine candidates in the fray were shortlisted after successful toxicity studies in animals.
Updated on Jul 14, 2020 06:38 pm IST

The intersection of politics and science, writes Chanakya

A priest and a labourer wear personal protective equipment (PPE) at a crematorium, amid the spread of the coronavirus disease in New Delhi, India, July 3, 2020.
Updated on Jul 05, 2020 06:03 am IST

WHO approves India’s cost-effective TB test

At 2.7 million new infections, India is home to almost a quarter of the world’s TB patients. The Indian government has set an ambitious target of eliminating the disease by 2025- five years before the global target. (Image used for representation).
Updated on Jan 17, 2020 12:37 am IST

National Aids Research Institute to drop focus on HIV, undergo name change

the National Aids Research Institute (NARI) is set to drop its focus on research into the Acquired Immuno-deficiency Syndrome (Aids) and also undergo a name change in the coming months.
Updated on Feb 17, 2019 07:45 am IST